infigratinib
helsinn,pfizer,bridgebio,xediton pharmaceuticals
['infigratinib']
we are pleased that results on a preclinical study on vepafestinib (tas0953/hm06), an investigational product targeting several ret abnormalities, and infigratinib, a small kinase inhibitor of fgfr, will be shared at . #asco22 
Helsinn is a fully integrated, global biopharma company focused on improving the lives of cancer patients all over the world. https://t.co/NUziRuBgtr